Article Information
History
- October 26, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Lotus L. van den Hoogen1,*,
- Marije K. Verheul1,*,
- Eric R.A. Vos2,
- Cheyenne C.E. van Hagen2,
- Michiel van Boven2,
- Denise Wong2,
- Alienke J. Wijmenga-Monsuur1,
- Gaby Smit1,
- Marjan Kuijer1,
- Debbie van Rooijen1,
- Marjan Bogaard-van Maurik1,
- Ilse Zutt1,
- Jeffrey van Vliet1,
- Fiona R.M. van der Klis1,
- Hester E. de Melker2,
- Robert S. van Binnendijk1 and
- Gerco den Hartog1,#
- 1Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
- 2Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
- ↵#Corresponding author: Gerco den Hartog, gerco.den.hartog{at}rivm.nl, Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, The Netherlands
↵* These authors contributed equally.
Posted October 26, 2021.
SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA- versus vector-based vaccination in the general Dutch population
